JP Morgan Chase
CYAD

JP Morgan Chase’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

JP Morgan Chase’s Portfolio CYAD Stock Details CYAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,000
Closed -$12K – 7125
2021
Q3 		$12K Buy
+3,000
New +$13.1K ﹤0.01% 6146
2020
Q3 		– Sell
-4
Closed – – 5893
2020
Q2 		$0 Buy
+4
New +$39 ﹤0.01% 5807

Other funds holding CYAD

FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase's CYAD Position: Q4 2021 in Review

JP Morgan Chase sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q4 2021, closing a stake of 3,000 shares — an estimated $12K sold.

JP Morgan Chase first reported a position in CYAD in Q2 2020 and held it in 2 quarters. The position peaked at $12K in Q3 2021. 10 funds tracked by Wall St. Rank hold CYAD as of Q4 2021.

  • JP Morgan Chase reported no remaining Celyad Oncology SA American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • JP Morgan Chase sold 3,000 Celyad Oncology SA American Depositary Shares shares in Q4 2021, an estimated $12K.
  • JP Morgan Chase first reported a position in Celyad Oncology SA American Depositary Shares in Q2 2020 and held it in 2 quarters.
  • JP Morgan Chase's Celyad Oncology SA American Depositary Shares position peaked at $12K in Q3 2021.
  • 10 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q4 2021.

Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.